Treatment of CAFs with MCF10.DCIS-CM resulted in an initial 4-fold upregulation of GM-CSF at day 1, followed by a greater-than-5-fold downregulation by day 8 (Figure 5B). The gene discussed is CSF2; the disease is ductal breast carcinoma in situ.